Comerica Bank’s 89bio ETNB Stock Holding History

Comerica Bank’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-188,031	Closed	-$2.76M	–	3742
2025 Q3	$2.76M	Buy	188,031 +28	+0%	+$285	0.01%	992
2025 Q2	$1.85M	Sell	188,003 -70,120	-27%	-$581K	0.01%	1182
2025 Q1	$1.88M	Buy	258,123 +1,540	+0.6%	+$13.5K	0.01%	1154
2024 Q4	$2.01M	Buy	256,583 +30,603	+14%	+$252K	0.01%	1135
2024 Q3	$1.67M	Buy	225,980 +49,913	+28%	+$420K	0.01%	1241
2024 Q2	$1.41M	Buy	176,067 +5,067	+3%	+$45.2K	0.01%	1302
2024 Q1	$1.99M	Buy	171,000 +15,070	+10%	+$167K	0.01%	1176
2023 Q4	$1.74M	Buy	155,930 +155,854	+205,071%	+$1.43M	0.01%	1247
2023 Q3	$1.18K	Buy	+76	New	+$1.28K	﹤0.01%	3644

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank's ETNB Position: Q4 2025 in Review

Comerica Bank sold out of 89bio (ETNB) in Q4 2025, closing a stake of 188,031 shares — an estimated $2.76M sold.

Comerica Bank first reported a position in ETNB in Q3 2023 and held it in 9 quarters. The position peaked at $2.76M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Comerica Bank reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Comerica Bank sold 188,031 89bio shares in Q4 2025, an estimated $2.76M.
Comerica Bank first reported a position in 89bio in Q3 2023 and held it in 9 quarters.
Comerica Bank's 89bio position peaked at $2.76M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.